BERLIN – At least 547 members of a prestigious Catholic boys’ choir in Germany were physically or sexually abused between 1945 and 1992, according to a report released Tuesday. Allegations involving the Domspatzen choir in Regensburg, which was run for 30 years by Emeritus Pope Benedict XVI’s elder brother, were among a spate of revelations...
NYS Entity Status
NYS Filing Date
OCTOBER 03, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION
2013 - NEW HOPE CHOIR
AROUND THE WEB
- Hundreds of boys physically and sexually abused at famed Catholic choir school: report
By Associated Press - Tuesday Jul 18, 2017
- Michelle Wie is out, and there goes US Women’s Open buzz
By Mark Cannizzaro - Friday Jul 14, 2017
The US Women’s Open lost a little bit of its star power Friday morning when Michelle Wie was forced to withdraw from the tournament at Trump National in Bedminster, NJ, citing a neck injury. Wie, whose opening round was suspended due to darkness on Thursday, completed it early Friday, finishing with a 1-over-par 73. Then,...
- New York Becomes the City That Never Shuts Up
By WINNIE HU - Wednesday Jul 19, 2017
With noise complaints doubling over five years and once-quiet neighborhoods offering little refuge, the city is considering a law to help quiet the din.
- Mets ‘little’ concerned about Yoenis Cespedes’ power outage
By Fred Kerber - Wednesday Jul 19, 2017
There is concern. And there should be. Yoenis Cespedes should be supplying power in bursts that carry the Mets for stretches, not just a game. Injuries have limited Cespedes, but even when he has been available, the results have lacked. So manager Terry Collins admitted there is concern. But there is hope, too. “There’s a...
- Trump Supporters Have a New Anthem, and It Came From Texas
By JACEY FORTIN - Tuesday Jul 11, 2017
A church choir and orchestra performed “Make America Great Again” earlier this month, and President Trump has spread it far and wide on Twitter.
- Merck Drug Shows No Life-Extending Benefit in Head-and-Neck Cancer
By Alex Lash - Monday Jul 24, 2017
The first immunotherapy approved in the U.S. to treat head and neck cancer has failed a big test, but it’s unclear if the FDA will exercise its right to pull it from the market. Merck (NYSE: MRK) announced late Monday that its blockbuster cancer drug pembrolizumab (Keytruda) did not meet its main goal of helping […]